Related Experiment Video

Updated: Mar 25, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.5K

Allicin inhibits human renal clear cell carcinoma progression via suppressing HIF pathway

Bin Song1, Ying Shu2, Tianlei Cui2

  • 1Department of Nephrology, The People's Hospital of Deyang Deyang, 618000, China.

International Journal of Clinical and Experimental Medicine
|February 18, 2016
PubMed

Insights

Allicin, a compound with anti-cancer properties, was found to inhibit renal clear cell carcinoma (RCC) progression. It works by suppressing the hypoxia-inducible factor 1-alpha (HIF-1α) pathway, reducing cell viability and migration.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Hypoxia-inducible factor 1-alpha (HIF-1α) is a key regulator of cellular response to low oxygen, protecting cells from death.
  • Renal clear cell carcinoma (RCC) is a significant health concern, and understanding its progression mechanisms is crucial.
  • Allicin, derived from garlic, exhibits known anti-cancer properties.

Purpose of the Study:

  • To investigate the role of allicin in the progression of renal clear cell carcinoma.
  • To determine if allicin affects the hypoxia-inducible factor 1-alpha (HIF-1α) pathway in RCC.
  • To elucidate the molecular mechanisms by which allicin influences RCC cell behavior.

Main Methods:

  • Analysis of 40 RCC and 39 normal renal tissues using H&E and immunohistochemistry.
  • Assessment of cell viability and apoptosis via MTT assay and flow cytometry.
  • Evaluation of cell migration and colony formation using in vitro assays.

Main Results:

  • Elevated protein levels of Bcl-2, VEGF, and HIF-1α were observed in RCC tissues.
  • Allicin treatment significantly reduced HIF-1α protein levels, subsequently decreasing Bcl-2 and VEGF expression.
  • Allicin enhanced apoptosis and reduced colony formation and migration in RCC cells, with HIF-1α overexpression partially counteracting these effects.

Conclusions:

  • Allicin demonstrates inhibitory effects on human renal clear cell carcinoma progression.
  • The anti-cancer activity of allicin in RCC is partially mediated by the suppression of the HIF-1α signaling pathway.
  • These findings suggest allicin as a potential therapeutic agent for RCC.
Keywords:
AllicinHIF1αRCCapoptosismigration

More Related Videos

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane05:36

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Published on: February 8, 2020

9.6K
An Orthotopic Murine Model of Human Prostate Cancer Metastasis06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

36.1K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.9K